Shape Therapeutics Inc.
Biotechnology-Research
Website
Company Tagline
The future of programmable RNA Medicines
Industry Category
Business Keywords
Company Description
Shape Therapeutics Inc. is at the forefront of biotechnology research, pioneering the future of programmable RNA medicines. Shape Therapeutics Inc. is dedicated to repairing the genetic causes of diseases through groundbreaking innovations in AI and RNA technology. By generating and analyzing hundreds of billions of therapeutic possibilities, Shape Therapeutics Inc. is developing breakthroughs in RNA editing, next-generation AAVs, and disruptive gene therapy manufacturing.
The Shape Therapeutics Inc. platform empowers pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions such as Alzheimer’s and Parkinson’s. Shape Therapeutics Inc. is located at Primary: 219 Terry Ave N, Seattle, Washington 98109, US, and is committed to advancing the field of RNA therapeutics to improve patient outcomes. Shape Therapeutics Inc. continues to expand its research and development efforts, solidifying its position as a leader in the biotechnology industry.
Shape Therapeutics Inc. is focused on creating impactful solutions for a variety of health challenges. With a strong foundation in cutting-edge science and a commitment to innovation, Shape Therapeutics Inc. is poised to make significant contributions to the future of medicine. We invite the manager of Shape Therapeutics Inc. to create a customized and exclusive company showcase and product listing on our platform to further enhance their commercial development.
Shape Therapeutics Inc. est à l'avant-garde de la recherche biotechnologique, ouvrant la voie à l'avenir des médicaments à ARN programmables. Shape Therapeutics Inc. se consacre à la réparation des causes génétiques des maladies grâce à des innovations révolutionnaires dans les domaines de l'IA et de la technologie de l'ARN. En générant et en analysant des centaines de milliards de possibilités thérapeutiques, Shape Therapeutics Inc. développe des avancées dans l'édition de l'ARN, les AAV de nouvelle génération et la fabrication disruptive de thérapie génique.
La plateforme de Shape Therapeutics Inc. permet aux innovateurs pharmaceutiques de concevoir des traitements pour un large éventail de maladies, y compris les maladies génétiques rares ainsi que les affections débilitantes telles que la maladie d'Alzheimer et la maladie de Parkinson. Shape Therapeutics Inc. est située à l'adresse suivante : Primary: 219 Terry Ave N, Seattle, Washington 98109, US, et s'engage à faire progresser le domaine des thérapies à ARN afin d'améliorer les résultats pour les patients. Shape Therapeutics Inc. continue d'étendre ses efforts de recherche et de développement, consolidant ainsi sa position de leader dans l'industrie biotechnologique.
Shape Therapeutics Inc. se concentre sur la création de solutions percutantes pour divers problèmes de santé. Forte d'une base scientifique de pointe et d'un engagement envers l'innovation, Shape Therapeutics Inc. est sur le point d'apporter une contribution significative à l'avenir de la médecine. Nous invitons le responsable de Shape Therapeutics Inc. à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin d'améliorer encore son développement commercial.
Key Personnel / Employees
Compare Companies Side by Side
Compare Shape Therapeutics Inc. with 3 companies in Biotechnology-Research
| Comparison Field |
Shape Therapeutics Inc.Main Company |
CRISPR Medicine NewsView Profile |
MaxCyte, Inc.View Profile |
AldevronView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2019 | 1999 | 1998 |
|
Company Size
|
— | 2-10 | 51-200 | 1,001-5,000 |
|
City
|
Seattle, Washington | Rockville, Maryland | Fargo, North Dakota | |
|
Country
|
United States | United States | United States | |
|
Skills & Keywords
Comparing with main company
|
10 Total Skills
RNA medicines
Biotechnology
Gene therapy
RNA editing
AAVs
Pharmaceuticals
Genetic disorders
RNA Editing
Gene Editing
Gene Therapy
|
8 Total
8 Unique
Unique Skills:
Cell Therapy
clinical trials
CRISPR
Genetic medicine
Interviews
Media
+2
|
19 Total
1 Common
18 Unique
Match
10%
Common Skills:
Biotechnology
Unique Skills:
Bispecifics
Cancer
Cancer Research
CARMA
Cell Engineering
Cell Therapy
+12
|
8 Total
8 Unique
Unique Skills:
Cell Therapy
cGMP
CRISPR/Cas9
GMP-Source
Messenger RNA (mRNA)
Plasmid DNA
+2
|
4
Total Companies1998
Oldest Founded1
Countries41
Unique SkillsSimilar Companies
Other organizations in the same industry
Asociación Vainilla Perú - AVAIPE
Biotechnology-ResearchPromoción e investigación de cadenas sostenibles de nuestra biodiversidad.
Allterum Therapeutics
Biotechnology-ResearchDeveloping Treatments for ALL.
Biodyne South Africa
Biotechnology-Research#Biodyneliquidgold
Alternative Company Names
This company is also known as